Long-term remedies can indicate inadequate enforcement, CMA head says

Behavioural remedies that continue long after the approval of a vertical merger are evidence that the deal “probably shouldn’t have been allowed in the first place,” the head of the UK’s Competition and Markets Authority has said.

Get unlimited access to all Global Competition Review content